Supernus Pharmaceuticals, Inc.
SUPN
Revenue
168.33M
▲24.68M▲17.18%
3 Months ChangeAssets
1.32B
▲11.74M▲0.9002%
3 Months ChangeLiabilities
358.38M
▼-16.55M▼-4.41%
3 Months ChangeFree Cash Flow
38.15M
▼-10.70M▼-21.89%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001356576-24-000062
2024-10-21
Form 8-K
ID: 0001356576-24-000060
2024-10-17
Form 8-K
ID: 0001356576-24-000058
2024-10-10
Form 8-K
ID: 0001356576-24-000056
2024-08-19
Form 8-K
ID: 0001356576-24-000053
2024-08-06
Form 10-Q
ID: 0001356576-24-000051
2024-08-06
Form 8-K
ID: 0001356576-24-000049
2024-08-01
Form 8-K
ID: 0001356576-24-000041
2024-07-23
Form 8-K
ID: 0001356576-24-000039
2024-06-17
Form 8-K
ID: 0001104659-24-072272